Covid-19 Impact on Intramuscular Injector Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Intramuscular Injector, including the following market information:
Major competitors identified in this market include Antares Pharma, Endo International Plc, Bioject Medical Technologies, PharmaJetMedical International Technology, National Medical Products, Valeritas, European Pharma Group, PenJet Corporation, Becton, Dickinson, Injex Pharma AG, Crossject SA, Solace Biotech, Sanify Healthcare Private Limited, Novosanis, Vata, Kaleo, etc.
Based on the Region:
- Global Intramuscular Injector Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Intramuscular Injector Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Intramuscular Injector Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Intramuscular Injector Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Major competitors identified in this market include Antares Pharma, Endo International Plc, Bioject Medical Technologies, PharmaJetMedical International Technology, National Medical Products, Valeritas, European Pharma Group, PenJet Corporation, Becton, Dickinson, Injex Pharma AG, Crossject SA, Solace Biotech, Sanify Healthcare Private Limited, Novosanis, Vata, Kaleo, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Pre-fillable Injection System
- Fillable Needle-free Injectors
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Intramuscular Injector Industry
1.7 COVID-19 Impact: Intramuscular Injector Market Trends
2 GLOBAL INTRAMUSCULAR INJECTOR QUARTERLY MARKET SIZE ANALYSIS
2.1 Intramuscular Injector Business Impact Assessment - COVID-19
2.1.1 Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Intramuscular Injector Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Intramuscular Injector Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Intramuscular Injector Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Intramuscular Injector Factory Price by Manufacturers
3.3 Location of Key Manufacturers Intramuscular Injector Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Intramuscular Injector Market
3.5 Key Manufacturers Intramuscular Injector Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INTRAMUSCULAR INJECTOR SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Pre-fillable Injection System
1.4.2 Fillable Needle-free Injectors
4.2 By Type, Global Intramuscular Injector Market Size, 2019-2021
4.2.1 By Type, Global Intramuscular Injector Market Size by Type, 2020-2021
4.2.2 By Type, Global Intramuscular Injector Price, 2020-2021
5 IMPACT OF COVID-19 ON INTRAMUSCULAR INJECTOR SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Ambulatory Surgery Centers
5.5.4 Others
5.2 By Application, Global Intramuscular Injector Market Size, 2019-2021
5.2.1 By Application, Global Intramuscular Injector Market Size by Application, 2019-2021
5.2.2 By Application, Global Intramuscular Injector Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Antares Pharma
7.1.1 Antares Pharma Business Overview
7.1.2 Antares Pharma Intramuscular Injector Quarterly Production and Revenue, 2020
7.1.3 Antares Pharma Intramuscular Injector Product Introduction
7.1.4 Antares Pharma Response to COVID-19 and Related Developments
7.2 Endo International Plc
7.2.1 Endo International Plc Business Overview
7.2.2 Endo International Plc Intramuscular Injector Quarterly Production and Revenue, 2020
7.2.3 Endo International Plc Intramuscular Injector Product Introduction
7.2.4 Endo International Plc Response to COVID-19 and Related Developments
7.3 Bioject Medical Technologies
7.3.1 Bioject Medical Technologies Business Overview
7.3.2 Bioject Medical Technologies Intramuscular Injector Quarterly Production and Revenue, 2020
7.3.3 Bioject Medical Technologies Intramuscular Injector Product Introduction
7.3.4 Bioject Medical Technologies Response to COVID-19 and Related Developments
7.4 PharmaJetMedical International Technology
7.4.1 PharmaJetMedical International Technology Business Overview
7.4.2 PharmaJetMedical International Technology Intramuscular Injector Quarterly Production and Revenue, 2020
7.4.3 PharmaJetMedical International Technology Intramuscular Injector Product Introduction
7.4.4 PharmaJetMedical International Technology Response to COVID-19 and Related Developments
7.5 National Medical Products
7.5.1 National Medical Products Business Overview
7.5.2 National Medical Products Intramuscular Injector Quarterly Production and Revenue, 2020
7.5.3 National Medical Products Intramuscular Injector Product Introduction
7.5.4 National Medical Products Response to COVID-19 and Related Developments
7.6 Valeritas
7.6.1 Valeritas Business Overview
7.6.2 Valeritas Intramuscular Injector Quarterly Production and Revenue, 2020
7.6.3 Valeritas Intramuscular Injector Product Introduction
7.6.4 Valeritas Response to COVID-19 and Related Developments
7.7 European Pharma Group
7.7.1 European Pharma Group Business Overview
7.7.2 European Pharma Group Intramuscular Injector Quarterly Production and Revenue, 2020
7.7.3 European Pharma Group Intramuscular Injector Product Introduction
7.7.4 European Pharma Group Response to COVID-19 and Related Developments
7.8 PenJet Corporation
7.8.1 PenJet Corporation Business Overview
7.8.2 PenJet Corporation Intramuscular Injector Quarterly Production and Revenue, 2020
7.8.3 PenJet Corporation Intramuscular Injector Product Introduction
7.8.4 PenJet Corporation Response to COVID-19 and Related Developments
7.9 Becton
7.9.1 Becton Business Overview
7.9.2 Becton Intramuscular Injector Quarterly Production and Revenue, 2020
7.9.3 Becton Intramuscular Injector Product Introduction
7.9.4 Becton Response to COVID-19 and Related Developments
7.10 Dickinson
7.10.1 Dickinson Business Overview
7.10.2 Dickinson Intramuscular Injector Quarterly Production and Revenue, 2020
7.10.3 Dickinson Intramuscular Injector Product Introduction
7.10.4 Dickinson Response to COVID-19 and Related Developments
7.11 Injex Pharma AG
7.11.1 Injex Pharma AG Business Overview
7.11.2 Injex Pharma AG Intramuscular Injector Quarterly Production and Revenue, 2020
7.11.3 Injex Pharma AG Intramuscular Injector Product Introduction
7.11.4 Injex Pharma AG Response to COVID-19 and Related Developments
7.12 Crossject SA
7.12.1 Crossject SA Business Overview
7.12.2 Crossject SA Intramuscular Injector Quarterly Production and Revenue, 2020
7.12.3 Crossject SA Intramuscular Injector Product Introduction
7.12.4 Crossject SA Response to COVID-19 and Related Developments
7.13 Solace Biotech
7.13.1 Solace Biotech Business Overview
7.13.2 Solace Biotech Intramuscular Injector Quarterly Production and Revenue, 2020
7.13.3 Solace Biotech Intramuscular Injector Product Introduction
7.13.4 Solace Biotech Response to COVID-19 and Related Developments
7.14 Sanify Healthcare Private Limited
7.14.1 Sanify Healthcare Private Limited Business Overview
7.14.2 Sanify Healthcare Private Limited Intramuscular Injector Quarterly Production and Revenue, 2020
7.14.3 Sanify Healthcare Private Limited Intramuscular Injector Product Introduction
7.14.4 Sanify Healthcare Private Limited Response to COVID-19 and Related Developments
7.15 Novosanis
7.15.1 Novosanis Business Overview
7.15.2 Novosanis Intramuscular Injector Quarterly Production and Revenue, 2020
7.15.3 Novosanis Intramuscular Injector Product Introduction
7.15.4 Novosanis Response to COVID-19 and Related Developments
7.16 Vata
7.16.1 Vata Business Overview
7.16.2 Vata Intramuscular Injector Quarterly Production and Revenue, 2020
7.16.3 Vata Intramuscular Injector Product Introduction
7.16.4 Vata Response to COVID-19 and Related Developments
7.17 Kaleo
7.17.1 Kaleo Business Overview
7.17.2 Kaleo Intramuscular Injector Quarterly Production and Revenue, 2020
7.17.3 Kaleo Intramuscular Injector Product Introduction
7.17.4 Kaleo Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Intramuscular Injector Supply Chain Analysis
8.1.1 Intramuscular Injector Supply Chain Analysis
8.1.2 Covid-19 Impact on Intramuscular Injector Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Intramuscular Injector Distribution Channels
8.2.2 Covid-19 Impact on Intramuscular Injector Distribution Channels
8.2.3 Intramuscular Injector Distributors
8.3 Intramuscular Injector Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Intramuscular Injector Industry
1.7 COVID-19 Impact: Intramuscular Injector Market Trends
2 GLOBAL INTRAMUSCULAR INJECTOR QUARTERLY MARKET SIZE ANALYSIS
2.1 Intramuscular Injector Business Impact Assessment - COVID-19
2.1.1 Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Intramuscular Injector Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Intramuscular Injector Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Intramuscular Injector Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Intramuscular Injector Factory Price by Manufacturers
3.3 Location of Key Manufacturers Intramuscular Injector Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Intramuscular Injector Market
3.5 Key Manufacturers Intramuscular Injector Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INTRAMUSCULAR INJECTOR SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Pre-fillable Injection System
1.4.2 Fillable Needle-free Injectors
4.2 By Type, Global Intramuscular Injector Market Size, 2019-2021
4.2.1 By Type, Global Intramuscular Injector Market Size by Type, 2020-2021
4.2.2 By Type, Global Intramuscular Injector Price, 2020-2021
5 IMPACT OF COVID-19 ON INTRAMUSCULAR INJECTOR SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Ambulatory Surgery Centers
5.5.4 Others
5.2 By Application, Global Intramuscular Injector Market Size, 2019-2021
5.2.1 By Application, Global Intramuscular Injector Market Size by Application, 2019-2021
5.2.2 By Application, Global Intramuscular Injector Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Antares Pharma
7.1.1 Antares Pharma Business Overview
7.1.2 Antares Pharma Intramuscular Injector Quarterly Production and Revenue, 2020
7.1.3 Antares Pharma Intramuscular Injector Product Introduction
7.1.4 Antares Pharma Response to COVID-19 and Related Developments
7.2 Endo International Plc
7.2.1 Endo International Plc Business Overview
7.2.2 Endo International Plc Intramuscular Injector Quarterly Production and Revenue, 2020
7.2.3 Endo International Plc Intramuscular Injector Product Introduction
7.2.4 Endo International Plc Response to COVID-19 and Related Developments
7.3 Bioject Medical Technologies
7.3.1 Bioject Medical Technologies Business Overview
7.3.2 Bioject Medical Technologies Intramuscular Injector Quarterly Production and Revenue, 2020
7.3.3 Bioject Medical Technologies Intramuscular Injector Product Introduction
7.3.4 Bioject Medical Technologies Response to COVID-19 and Related Developments
7.4 PharmaJetMedical International Technology
7.4.1 PharmaJetMedical International Technology Business Overview
7.4.2 PharmaJetMedical International Technology Intramuscular Injector Quarterly Production and Revenue, 2020
7.4.3 PharmaJetMedical International Technology Intramuscular Injector Product Introduction
7.4.4 PharmaJetMedical International Technology Response to COVID-19 and Related Developments
7.5 National Medical Products
7.5.1 National Medical Products Business Overview
7.5.2 National Medical Products Intramuscular Injector Quarterly Production and Revenue, 2020
7.5.3 National Medical Products Intramuscular Injector Product Introduction
7.5.4 National Medical Products Response to COVID-19 and Related Developments
7.6 Valeritas
7.6.1 Valeritas Business Overview
7.6.2 Valeritas Intramuscular Injector Quarterly Production and Revenue, 2020
7.6.3 Valeritas Intramuscular Injector Product Introduction
7.6.4 Valeritas Response to COVID-19 and Related Developments
7.7 European Pharma Group
7.7.1 European Pharma Group Business Overview
7.7.2 European Pharma Group Intramuscular Injector Quarterly Production and Revenue, 2020
7.7.3 European Pharma Group Intramuscular Injector Product Introduction
7.7.4 European Pharma Group Response to COVID-19 and Related Developments
7.8 PenJet Corporation
7.8.1 PenJet Corporation Business Overview
7.8.2 PenJet Corporation Intramuscular Injector Quarterly Production and Revenue, 2020
7.8.3 PenJet Corporation Intramuscular Injector Product Introduction
7.8.4 PenJet Corporation Response to COVID-19 and Related Developments
7.9 Becton
7.9.1 Becton Business Overview
7.9.2 Becton Intramuscular Injector Quarterly Production and Revenue, 2020
7.9.3 Becton Intramuscular Injector Product Introduction
7.9.4 Becton Response to COVID-19 and Related Developments
7.10 Dickinson
7.10.1 Dickinson Business Overview
7.10.2 Dickinson Intramuscular Injector Quarterly Production and Revenue, 2020
7.10.3 Dickinson Intramuscular Injector Product Introduction
7.10.4 Dickinson Response to COVID-19 and Related Developments
7.11 Injex Pharma AG
7.11.1 Injex Pharma AG Business Overview
7.11.2 Injex Pharma AG Intramuscular Injector Quarterly Production and Revenue, 2020
7.11.3 Injex Pharma AG Intramuscular Injector Product Introduction
7.11.4 Injex Pharma AG Response to COVID-19 and Related Developments
7.12 Crossject SA
7.12.1 Crossject SA Business Overview
7.12.2 Crossject SA Intramuscular Injector Quarterly Production and Revenue, 2020
7.12.3 Crossject SA Intramuscular Injector Product Introduction
7.12.4 Crossject SA Response to COVID-19 and Related Developments
7.13 Solace Biotech
7.13.1 Solace Biotech Business Overview
7.13.2 Solace Biotech Intramuscular Injector Quarterly Production and Revenue, 2020
7.13.3 Solace Biotech Intramuscular Injector Product Introduction
7.13.4 Solace Biotech Response to COVID-19 and Related Developments
7.14 Sanify Healthcare Private Limited
7.14.1 Sanify Healthcare Private Limited Business Overview
7.14.2 Sanify Healthcare Private Limited Intramuscular Injector Quarterly Production and Revenue, 2020
7.14.3 Sanify Healthcare Private Limited Intramuscular Injector Product Introduction
7.14.4 Sanify Healthcare Private Limited Response to COVID-19 and Related Developments
7.15 Novosanis
7.15.1 Novosanis Business Overview
7.15.2 Novosanis Intramuscular Injector Quarterly Production and Revenue, 2020
7.15.3 Novosanis Intramuscular Injector Product Introduction
7.15.4 Novosanis Response to COVID-19 and Related Developments
7.16 Vata
7.16.1 Vata Business Overview
7.16.2 Vata Intramuscular Injector Quarterly Production and Revenue, 2020
7.16.3 Vata Intramuscular Injector Product Introduction
7.16.4 Vata Response to COVID-19 and Related Developments
7.17 Kaleo
7.17.1 Kaleo Business Overview
7.17.2 Kaleo Intramuscular Injector Quarterly Production and Revenue, 2020
7.17.3 Kaleo Intramuscular Injector Product Introduction
7.17.4 Kaleo Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Intramuscular Injector Supply Chain Analysis
8.1.1 Intramuscular Injector Supply Chain Analysis
8.1.2 Covid-19 Impact on Intramuscular Injector Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Intramuscular Injector Distribution Channels
8.2.2 Covid-19 Impact on Intramuscular Injector Distribution Channels
8.2.3 Intramuscular Injector Distributors
8.3 Intramuscular Injector Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Intramuscular Injector Assessment
Table 9. COVID-19 Impact: Intramuscular Injector Market Trends
Table 10. COVID-19 Impact Global Intramuscular Injector Market Size
Table 11. Global Intramuscular Injector Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Intramuscular Injector Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Intramuscular Injector Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Intramuscular Injector Market Growth Drivers
Table 17. Global Intramuscular Injector Market Restraints
Table 18. Global Intramuscular Injector Market Opportunities
Table 19. Global Intramuscular Injector Market Challenges
Table 20. Key Manufacturers Intramuscular Injector Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Intramuscular Injector Market Size, 2019 (K Units) & (US$ Million)
Table 22. Intramuscular Injector Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Intramuscular Injector Manufacturing Plants
Table 24. Key Manufacturers Intramuscular Injector Market Served
Table 25. Date of Key Manufacturers Enter into Intramuscular Injector Market
Table 26. Key Manufacturers Intramuscular Injector Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Intramuscular Injector Market Size by Type, 2020, (US$ Million)
Table 29. Global Intramuscular Injector Market Size by Type, 2020 (K Units)
Table 30. Global Intramuscular Injector Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Intramuscular Injector Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Intramuscular Injector Market Size by Application, 2020-2021 (K Units)
Table 33. Global Intramuscular Injector Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Intramuscular Injector Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Intramuscular Injector Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Intramuscular Injector Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Intramuscular Injector Market Size, 2019-2021 (K Units)
Table 38. US Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Intramuscular Injector Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Intramuscular Injector Market Size, 2019-2021 (K Units)
Table 43. Germany Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Intramuscular Injector Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Intramuscular Injector Market Size, 2019-2021 (K Units)
Table 50. China Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Antares Pharma Business Overview
Table 58. Antares Pharma Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Antares Pharma Intramuscular Injector Product
Table 60. Antares Pharma Response to COVID-19 and Related Developments
Table 61. Endo International Plc Business Overview
Table 62. Endo International Plc Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Endo International Plc Intramuscular Injector Product
Table 64. Endo International Plc Response to COVID-19 and Related Developments
Table 65. Bioject Medical Technologies Business Overview
Table 66. Bioject Medical Technologies Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bioject Medical Technologies Intramuscular Injector Product
Table 68. Bioject Medical Technologies Response to COVID-19 and Related Developments
Table 69. PharmaJetMedical International Technology Business Overview
Table 70. PharmaJetMedical International Technology Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. PharmaJetMedical International Technology Intramuscular Injector Product
Table 72. PharmaJetMedical International Technology Response to COVID-19 and Related Developments
Table 73. National Medical Products Business Overview
Table 74. National Medical Products Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. National Medical Products Intramuscular Injector Product
Table 76. National Medical Products Response to COVID-19 and Related Developments
Table 77. Valeritas Business Overview
Table 78. Valeritas Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Valeritas Intramuscular Injector Product
Table 80. Valeritas Response to COVID-19 and Related Developments
Table 81. European Pharma Group Business Overview
Table 82. European Pharma Group Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. European Pharma Group Intramuscular Injector Product
Table 84. European Pharma Group Response to COVID-19 and Related Developments
Table 85. PenJet Corporation Business Overview
Table 86. PenJet Corporation Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. PenJet Corporation Intramuscular Injector Product
Table 88. PenJet Corporation Response to COVID-19 and Related Developments
Table 89. Becton Business Overview
Table 90. Becton Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Becton Intramuscular Injector Product
Table 92. Becton Response to COVID-19 and Related Developments
Table 93. Dickinson Business Overview
Table 94. Dickinson Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Dickinson Intramuscular Injector Product
Table 96. Dickinson Response to COVID-19 and Related Developments
Table 97. Injex Pharma AG Business Overview
Table 98. Injex Pharma AG Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Injex Pharma AG Intramuscular Injector Product
Table 100. Injex Pharma AG Response to COVID-19 and Related Developments
Table 101. Crossject SA Business Overview
Table 102. Crossject SA Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Crossject SA Intramuscular Injector Product
Table 104. Crossject SA Response to COVID-19 and Related Developments
Table 105. Solace Biotech Business Overview
Table 106. Solace Biotech Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Solace Biotech Intramuscular Injector Product
Table 108. Solace Biotech Response to COVID-19 and Related Developments
Table 109. Sanify Healthcare Private Limited Business Overview
Table 110. Sanify Healthcare Private Limited Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Sanify Healthcare Private Limited Intramuscular Injector Product
Table 112. Sanify Healthcare Private Limited Response to COVID-19 and Related Developments
Table 113. Novosanis Business Overview
Table 114. Novosanis Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Novosanis Intramuscular Injector Product
Table 116. Novosanis Response to COVID-19 and Related Developments
Table 117. Vata Business Overview
Table 118. Vata Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Vata Intramuscular Injector Product
Table 120. Vata Response to COVID-19 and Related Developments
Table 121. Kaleo Business Overview
Table 122. Kaleo Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Kaleo Intramuscular Injector Product
Table 124. Kaleo Response to COVID-19 and Related Developments
Table 125. Intramuscular Injector Distributors List
Table 126. Intramuscular Injector Customers List
Table 127. Covid-19 Impact on Intramuscular Injector Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Intramuscular Injector Assessment
Table 9. COVID-19 Impact: Intramuscular Injector Market Trends
Table 10. COVID-19 Impact Global Intramuscular Injector Market Size
Table 11. Global Intramuscular Injector Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Intramuscular Injector Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Intramuscular Injector Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Intramuscular Injector Market Growth Drivers
Table 17. Global Intramuscular Injector Market Restraints
Table 18. Global Intramuscular Injector Market Opportunities
Table 19. Global Intramuscular Injector Market Challenges
Table 20. Key Manufacturers Intramuscular Injector Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Intramuscular Injector Market Size, 2019 (K Units) & (US$ Million)
Table 22. Intramuscular Injector Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Intramuscular Injector Manufacturing Plants
Table 24. Key Manufacturers Intramuscular Injector Market Served
Table 25. Date of Key Manufacturers Enter into Intramuscular Injector Market
Table 26. Key Manufacturers Intramuscular Injector Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Intramuscular Injector Market Size by Type, 2020, (US$ Million)
Table 29. Global Intramuscular Injector Market Size by Type, 2020 (K Units)
Table 30. Global Intramuscular Injector Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Intramuscular Injector Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Intramuscular Injector Market Size by Application, 2020-2021 (K Units)
Table 33. Global Intramuscular Injector Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Intramuscular Injector Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Intramuscular Injector Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Intramuscular Injector Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Intramuscular Injector Market Size, 2019-2021 (K Units)
Table 38. US Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Intramuscular Injector Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Intramuscular Injector Market Size, 2019-2021 (K Units)
Table 43. Germany Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Intramuscular Injector Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Intramuscular Injector Market Size, 2019-2021 (K Units)
Table 50. China Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Intramuscular Injector Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Antares Pharma Business Overview
Table 58. Antares Pharma Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Antares Pharma Intramuscular Injector Product
Table 60. Antares Pharma Response to COVID-19 and Related Developments
Table 61. Endo International Plc Business Overview
Table 62. Endo International Plc Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Endo International Plc Intramuscular Injector Product
Table 64. Endo International Plc Response to COVID-19 and Related Developments
Table 65. Bioject Medical Technologies Business Overview
Table 66. Bioject Medical Technologies Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Bioject Medical Technologies Intramuscular Injector Product
Table 68. Bioject Medical Technologies Response to COVID-19 and Related Developments
Table 69. PharmaJetMedical International Technology Business Overview
Table 70. PharmaJetMedical International Technology Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. PharmaJetMedical International Technology Intramuscular Injector Product
Table 72. PharmaJetMedical International Technology Response to COVID-19 and Related Developments
Table 73. National Medical Products Business Overview
Table 74. National Medical Products Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. National Medical Products Intramuscular Injector Product
Table 76. National Medical Products Response to COVID-19 and Related Developments
Table 77. Valeritas Business Overview
Table 78. Valeritas Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Valeritas Intramuscular Injector Product
Table 80. Valeritas Response to COVID-19 and Related Developments
Table 81. European Pharma Group Business Overview
Table 82. European Pharma Group Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. European Pharma Group Intramuscular Injector Product
Table 84. European Pharma Group Response to COVID-19 and Related Developments
Table 85. PenJet Corporation Business Overview
Table 86. PenJet Corporation Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. PenJet Corporation Intramuscular Injector Product
Table 88. PenJet Corporation Response to COVID-19 and Related Developments
Table 89. Becton Business Overview
Table 90. Becton Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Becton Intramuscular Injector Product
Table 92. Becton Response to COVID-19 and Related Developments
Table 93. Dickinson Business Overview
Table 94. Dickinson Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Dickinson Intramuscular Injector Product
Table 96. Dickinson Response to COVID-19 and Related Developments
Table 97. Injex Pharma AG Business Overview
Table 98. Injex Pharma AG Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Injex Pharma AG Intramuscular Injector Product
Table 100. Injex Pharma AG Response to COVID-19 and Related Developments
Table 101. Crossject SA Business Overview
Table 102. Crossject SA Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Crossject SA Intramuscular Injector Product
Table 104. Crossject SA Response to COVID-19 and Related Developments
Table 105. Solace Biotech Business Overview
Table 106. Solace Biotech Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Solace Biotech Intramuscular Injector Product
Table 108. Solace Biotech Response to COVID-19 and Related Developments
Table 109. Sanify Healthcare Private Limited Business Overview
Table 110. Sanify Healthcare Private Limited Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Sanify Healthcare Private Limited Intramuscular Injector Product
Table 112. Sanify Healthcare Private Limited Response to COVID-19 and Related Developments
Table 113. Novosanis Business Overview
Table 114. Novosanis Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Novosanis Intramuscular Injector Product
Table 116. Novosanis Response to COVID-19 and Related Developments
Table 117. Vata Business Overview
Table 118. Vata Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Vata Intramuscular Injector Product
Table 120. Vata Response to COVID-19 and Related Developments
Table 121. Kaleo Business Overview
Table 122. Kaleo Intramuscular Injector Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Kaleo Intramuscular Injector Product
Table 124. Kaleo Response to COVID-19 and Related Developments
Table 125. Intramuscular Injector Distributors List
Table 126. Intramuscular Injector Customers List
Table 127. Covid-19 Impact on Intramuscular Injector Customers
LIST OF FIGURES
Figure 1. Intramuscular Injector Product Picture
Figure 2. Intramuscular Injector Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Intramuscular Injector Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Intramuscular Injector Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Intramuscular Injector Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Intramuscular Injector Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Intramuscular Injector Market Size Market Share, 2019-2021
Figure 1. Intramuscular Injector Product Picture
Figure 2. Intramuscular Injector Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Intramuscular Injector Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Intramuscular Injector Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Intramuscular Injector Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Intramuscular Injector Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Intramuscular Injector Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Intramuscular Injector Market Size Market Share, 2019-2021
